Literature DB >> 28072757

Organ Procurement Organization Survey of Practices and Beliefs Regarding Prerecovery Percutaneous Liver Biopsy in Donation After Neurologic Determination of Death.

Joseph Benton Oliver1, Andrea Fleisch Marcus, Mark Paster, Joseph Nespral, Advaith Bongu, George Dikdan, Lloyd Brown, Nikole Neidlinger, Baburao Koneru.   

Abstract

BACKGROUND: Prerecovery liver biopsy (PLB) allows histological evaluation of the organ before procurement. The opinions and what factors might influence PLB use within Organ Procurement Organizations (OPOs) are unknown.
METHODS: A survey instrument was distributed by the Association of OPOs to the clinical directors of all 58 OPOs. Descriptive statistics were calculated. Results were also stratified based on OPO characteristics.
RESULTS: Forty-nine (84.5%) of 58 OPOs responded to the survey; 40 (81.6%) of 49 currently perform PLB. This did not vary based on land mass, population, livers discarded, transplanted, donor age, or recipient MELD scores. Donor age, obesity, alcohol abuse, hepatitis serology, liver only donor, imaging results, and transplant center request were the most common indications for PLB in over 80% of OPOs. The median rate of performance is 5% to 10% of donors. Most use interventional radiologists to perform and the donor hospital pathologist/s to interpret PLB. Most OPOs believe PLBs are safe, reliable, useful, and performed often enough. Most say they did not believe they are easy to obtain. Beliefs were mixed regarding accuracy. The topics likely to influence PLB use were utility and accuracy of PLB, and availability of staff to perform PLB. OPOs that perform PLB more often were more likely to have favorable opinions of safety and pathologist availability, and more influenced by safety, reliability, availability, and a national consensus on the use of PLB.
CONCLUSIONS: Considerable variability exists in the use of PLB. Additional information on the utility, accuracy, and safety of PLB are needed to optimize its use.

Entities:  

Mesh:

Year:  2017        PMID: 28072757      PMCID: PMC7228602          DOI: 10.1097/TP.0000000000001632

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  28 in total

1.  Use of percutaneous liver biopsies in marginal liver donors.

Authors:  S Ganz; K Abdullah; R Gedaly; S Henry; L Cravero; L Olson; T Kato; J Miller; A Tzakis
Journal:  Transplant Proc       Date:  2001 Feb-Mar       Impact factor: 1.066

Review 2.  Hepatic steatosis and liver transplantation current clinical and experimental perspectives.

Authors:  Baburao Koneru; George Dikdan
Journal:  Transplantation       Date:  2002-02-15       Impact factor: 4.939

Review 3.  When is steatosis too much for transplantation?

Authors:  Antonio Nocito; Ashraf Mohammad El-Badry; Pierre-Alain Clavien
Journal:  J Hepatol       Date:  2006-07-31       Impact factor: 25.083

4.  Prerecovery liver biopsy in the brain-dead donor: a case-control study of logistics, safety, precision, and utility.

Authors:  Joseph Benton Oliver; Stephen Peters; Advaith Bongu; Abdel-Kareem Beidas; George Dikdan; Lloyd Brown; Baburao Koneru
Journal:  Liver Transpl       Date:  2014-01-02       Impact factor: 5.799

5.  The optimal number of donor biopsy sites to evaluate liver histology for transplantation.

Authors:  Wendy L Frankel; Jason G Tranovich; Laura Salter; Ginny Bumgardner; Peter Baker
Journal:  Liver Transpl       Date:  2002-11       Impact factor: 5.799

6.  Analysis of discarded livers for transplantation.

Authors:  A Escartín; E Castro; C Dopazo; J Bueno; I Bilbao; C Margarit
Journal:  Transplant Proc       Date:  2005-11       Impact factor: 1.066

7.  When the living and the deceased cannot agree on organ donation: a survey of US organ procurement organizations (OPOs).

Authors:  W J Chon; M A Josephson; E J Gordon; Y T Becker; P Witkowski; D J Arwindekar; A Naik; J R Thistlethwaite; C Liao; L F Ross
Journal:  Am J Transplant       Date:  2014-01       Impact factor: 8.086

8.  National Organ Retrieval Imaging System: results of the pilot study.

Authors:  Mettu S Reddy; Chandrashekhar Bhati; Desley Neil; Darius F Mirza; Derek M Manas
Journal:  Transpl Int       Date:  2008-11       Impact factor: 3.782

9.  Sampling variability on percutaneous liver biopsy.

Authors:  W Abdi; J C Millan; E Mezey
Journal:  Arch Intern Med       Date:  1979-06

10.  Declining liver utilization for transplantation in the United States and the impact of donation after cardiac death.

Authors:  Eric S Orman; A Sidney Barritt; Stephanie B Wheeler; Paul H Hayashi
Journal:  Liver Transpl       Date:  2013-01       Impact factor: 5.799

View more
  1 in total

1.  [Percutaneous liver biopsy before organ removal-Impact on organ allocation and costs in liver transplantation].

Authors:  Christian Beltzer; Markus Quante; Myriam Rheinberger; Hideo Andreas Baba; Fuat Saner; Falko Fend; Thomas Biet; Alfred Königsrainer; Silvio Nadalin
Journal:  Chirurg       Date:  2021-01       Impact factor: 0.955

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.